Evidence map›Paper›PMID 40090722›Full record

ArticleInternal medicine (Tokyo, Japan)2025

Usefulness of Repeated Lusutrombopag Administration in Clinical Practice and Its Correlation with the Simulation Software-Predicted Platelet Count: A Multicenter Study.

Takushi Manabe, Chikara Ogawa, Takashi Tamada, Naoki Yoshioka, Takehiro Akahane, Hideki Fujii, Hirotaka Arai, Kei Takuma, Mai Nakahara, Kyoko Oura and 12 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Takushi ManabeDepartment of Gastroenterology and Hepatology, Takamatsu Red Cross Hospital, Japan.
Chikara OgawaDepartment of Gastroenterology and Hepatology, Takamatsu Red Cross Hospital, Japan.
Takashi TamadaDepartment of Gastroenterology, Takatsuki Red Cross Hospital, Japan.
Naoki YoshiokaDepartment of Gastroenterology and Hepatology, Japanese Red Cross Nagoya Daiichi Hospital, Japan.
Takehiro AkahaneDepartment of Gastroenterology, Ishinomaki Red Cross Hospital, Japan.
Hideki FujiiDepartment of Gastroenterology, Japanese Red Cross Society Kyoto Daiichi Hospital, Japan.
Hirotaka AraiDepartment of Gastroenterology, Maebashi Red Cross Hospital, Japan.
Kei TakumaDepartment of Gastroenterology and Neurology, Kagawa University Faculty of Medicine, Japan.
Mai NakaharaDepartment of Gastroenterology and Neurology, Kagawa University Faculty of Medicine, Japan.
Kyoko OuraDepartment of Gastroenterology and Neurology, Kagawa University Faculty of Medicine, Japan.
Tomoko TadokoroDepartment of Gastroenterology and Neurology, Kagawa University Faculty of Medicine, Japan.
Koji FujitaDepartment of Gastroenterology and Neurology, Kagawa University Faculty of Medicine, Japan.
Joji TaniDepartment of Gastroenterology and Neurology, Kagawa University Faculty of Medicine, Japan.
Asahiro MorishitaDepartment of Gastroenterology and Neurology, Kagawa University Faculty of Medicine, Japan.
Hideki KobaraDepartment of Gastroenterology and Neurology, Kagawa University Faculty of Medicine, Japan.
Shinichiro NakamuraDepartment of Internal Medicine, Himeji Red Cross Hospital, Japan.
Hironori OchiCenter for Liver-Biliary-Pancreatic Disease, Matsuyama Red Cross Hospital, Japan.
Shintaro TakakiDepartment of Gastroenterology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Japan.
Nami MoriDepartment of Gastroenterology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Japan.
Keiji TsujiDepartment of Gastroenterology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Japan.
Masayuki KurosakiDepartment of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Japan.
Namiki IzumiDepartment of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective Lusutrombopag is recommended for severe thrombocytopenia (<5.0×10

Indexed as

CinnamatesSoftwareThiazolesThrombocytopeniaAdultAgedAged, 80 and overComputer SimulationFemaleHumansJapanMaleMiddle AgedPlatelet CountRetrospective StudiesCinnamateslusutrombopagThiazolescirrhosishepatitisliver tumorlusutrombopagplatelet countrepeated administration

Identifiers

PMID40090722
PMCPMC12508629

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.